Decreased NKG2D expression on CD8+ T cell is involved in immune evasion in patients with gastric cancer

被引:42
|
作者
Osaki, Tomohiro [1 ]
Saito, Hiroaki [1 ]
Yoshikawa, Toshiaki [1 ]
Matsumoto, Sachiko [1 ]
Tatebe, Shigeru [1 ]
Tsujitani, Shunichi [1 ]
Ikeguchi, Masahide [1 ]
机构
[1] Tottori Univ, Sch Med, Dept Surg, Div Surg Oncol, Yonago, Tottori 6838504, Japan
关键词
D O I
10.1158/1078-0432.CCR-06-1454
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Some studies suggest that the immunoreceptor NKG2D expression on CD8(+) T cells is down-regulated and this reduction may be involved in immune evasion in cancer patients. The present study was designed to investigate NKG2D expression on CD8(+) T lymphocytes and its relationship to immune evasion in gastric cancer patients. Experimental Design: NKG2D expression on both circulating and tumor-infiltrating CD8(+) T cells was evaluated by multicolor flow cytometry. Soluble MHC class I chain-related gene A (MICA) in the sera was quantitated by ELISA. Transwell experiments were carried out to determine the effect of cancer cells on NKG2D expression. Results: NKG2D expression on circulating CD8(+) Tcells was down-regulated and significantly correlated with IFN-gamma production in gastric cancer patients (r = 0.68; P = 0.007). NKG2D expression was closely related to undifferentiated cancer (P = 0.021) as was the depth of invasion (P = 0.012). There was no difference in soluble MICA between gastric cancer patients and normal controls. NKG2D expression on CD8(+) Tcells was remarkably reduced in the tissue of gastric cancer compared with peripheral blood (P = 0.046). Complete removal of tumor by surgery restored NKG2D expression on CD8(+) Tcells (P = 0.0049). Transwell experiments showed that this down-regulation was induced by direct contact between cancer cells and CD8(+) Tcells and that soluble factors did not affect the NKG2D expression. This phenomenon was blocked by the addition of anti-MICA antibodies. Conclusions: Decreased NKG2D expression may be one of the key mechanisms responsible for immune evasion by tumors in gastric cancer.
引用
收藏
页码:382 / 387
页数:6
相关论文
共 50 条
  • [21] NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses
    Andrew Zloza
    Frederick J Kohlhapp
    Gretchen E Lyons
    Jason M Schenkel
    Tamson V Moore
    Andrew T Lacek
    Jeremy A O'Sullivan
    Vineeth Varanasi
    Jesse W Williams
    Michael C Jagoda
    Emily C Bellavance
    Amanda L Marzo
    Paul G Thomas
    Biljana Zafirova
    Bojan Polić
    Lena Al-Harthi
    Anne I Sperling
    José A Guevara-Patiño
    Nature Medicine, 2012, 18 : 422 - 428
  • [22] NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses
    Zloza, Andrew
    Kohlhapp, Frederick J.
    Lyons, Gretchen E.
    Schenkel, Jason M.
    Moore, Tamson V.
    Lacek, Andrew T.
    O'Sullivan, Jeremy A.
    Varanasi, Vineeth
    Williams, Jesse W.
    Jagoda, Michael C.
    Bellavance, Emily C.
    Marzo, Amanda L.
    Thomas, Paul G.
    Zafirova, Biljana
    Polic, Bojan
    Al-Harthi, Lena
    Sperling, Anne I.
    Guevara-Patino, Jose A.
    NATURE MEDICINE, 2012, 18 (03) : 422 - U184
  • [23] Tumor cell secretome induces the expression of the immune checkpoint NKG2A on CD8+ T cells
    Rodriguez-Garcia, Gabriel J.
    Schares, Henry A.
    Bachmann, Brian O.
    Kim, Young J.
    Korrer, Michael J.
    Rathmell, Jeffrey C.
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [24] HCMV variants expressing ULBP2 modulate NKG2D expression and function on NK and CD8+ T cells
    Meyer, G.
    Siemes, R.
    Kuehne, J. F.
    Keil, J.
    Beushausen, K.
    Wagner, K.
    Steinbrueck, L.
    Borst, E. -M.
    Messerle, M.
    Falk, C. S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 371 - 371
  • [26] NKG2D ligand-inducing immune therapy plus NKG2D+CD8+T cell therapy overcomes chemoresistance in tumors
    Hu, Jiemiao
    Batth, Izhar
    Bernatchez, Chantale
    Xia, Xueqing
    Hwu, Patrick
    Gorlick, Richard
    Li, Shulin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [27] TGF-β downregulates the activating receptor NKG2D on NK cells and CD8+ T cells glioma patients
    Crane, Courtney A.
    Han, Seunggu J.
    Barry, Jeffery J.
    Ahn, Brian J.
    Lanier, Lewis L.
    Parsa, Andrew T.
    NEURO-ONCOLOGY, 2010, 12 (01) : 7 - 13
  • [28] An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer
    Shuichi Takano
    Hiroaki Saito
    Masahide Ikeguchi
    Surgery Today, 2016, 46 : 1341 - 1347
  • [29] Costimulation through NKG2D enhances murine CD8+ CTL function:: Similarities and differences between NKG2D and CD28 costimulation
    Markiewicz, MA
    Carayannopoulos, LN
    Naidenko, OV
    Matsui, K
    Burack, WR
    Wise, EL
    Fremont, DH
    Allen, PM
    Yokoyama, WM
    Colonna, M
    Shaw, AS
    JOURNAL OF IMMUNOLOGY, 2005, 175 (05): : 2825 - 2833
  • [30] NKG2D triggers MHC I unrestricted effector function of alloreactive CD8+ T cells
    Stoelcker, B.
    Kraetzel, K.
    Pfeifer, M.
    Schulz, C.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 123 - 123